BIT
ACHN

BlackRock Institutional Trust’s Achillion Pharmaceuticals ACHN Stock Holding History

BlackRock Institutional Trust’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$16M Buy
3,867,795
+460,419
+14% +$2.45M ﹤0.01% 2130
2016
Q3 		$27.6M Buy
3,407,376
+385,973
+13% +$3.28M ﹤0.01% 1658
2016
Q2 		$23.6M Buy
3,021,403
+136,258
+5% +$1.17M ﹤0.01% 1747
2016
Q1 		$22.3M Sell
2,885,145
-30,698
-1% -$225K ﹤0.01% 1756
2015
Q4 		$31.5M Buy
2,915,843
+89,770
+3% +$816K 0.01% 1551
2015
Q3 		$19.5M Buy
2,826,073
+109,962
+4% +$896K ﹤0.01% 1856
2015
Q2 		$24.1M Sell
2,716,111
-158,528
-6% -$1.5M ﹤0.01% 1796
2015
Q1 		$28.3M Buy
2,874,639
+343,036
+14% +$4.28M ﹤0.01% 1713
2014
Q4 		$31M Sell
2,531,603
-77,962
-3% -$952K 0.01% 1622
2014
Q3 		$26M Sell
2,609,565
-455,803
-15% -$4.23M ﹤0.01% 1718
2014
Q2 		$23.2M Sell
3,065,368
-82,828
-3% -$330K ﹤0.01% 1859
2014
Q1 		$10.4M Buy
3,148,196
+157,991
+5% +$553K ﹤0.01% 2399
2013
Q4 		$9.92M Buy
2,990,205
+285,301
+11% +$828K ﹤0.01% 2423
2013
Q3 		$8.17M Buy
2,704,904
+297,469
+12% +$2.04M ﹤0.01% 2483
2013
Q2 		$19.7M Buy
+2,407,435
New +$18.4M ﹤0.01% 1822

Other funds holding ACHN

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock Institutional Trust's ACHN Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Achillion Pharmaceuticals (ACHN) stake by 14% in Q4 2016, buying an estimated $2.45M and bringing the position to 3,867,795 shares worth $16M. The position accounts for ﹤0.01% of the portfolio, ranked #2130.

BlackRock Institutional Trust first reported a position in ACHN in Q2 2013 and has held it in 15 quarters since. The position peaked at $31.5M in Q4 2015. 140 funds tracked by Wall St. Rank hold ACHN as of Q4 2016.

  • BlackRock Institutional Trust held 3,867,795 shares of Achillion Pharmaceuticals worth $16M as of Q4 2016.
  • BlackRock Institutional Trust bought 460,419 Achillion Pharmaceuticals shares in Q4 2016, an estimated $2.45M.
  • Achillion Pharmaceuticals made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2130 holding.
  • BlackRock Institutional Trust first reported a position in Achillion Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Achillion Pharmaceuticals position peaked at $31.5M in Q4 2015.
  • 140 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.